+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 45Years +
All Genders
ID04743765

HIP ATTACK-2 Trial Evaluating Accelerated Surgery Versus Standard Care for Hip Fracture Patients with Acute Myocardial Injury

Led by Population Health Research Institute · Updated on 2026-08-26

1100

Participants Needed

77

Research Sites

13 weeks

Total Duration

AI-Summary

What This Trial Is About

The HIP ATTACK-2 trial is an international, multicenter randomized controlled study investigating whether accelerated surgery for patients with hip fractures and acute myocardial injury reduces death within 90 days compared to standard care. The trial also evaluates secondary outcomes such as the ability to walk independently, time to first mobilization, major complications including heart and stroke events, delirium, length of hospital stay, pain, and quality of life. Participants are assigned to either accelerated medical clearance with surgery within 6 hours of meeting eligibility or to standard surgical care following hospital guidelines. The accelerated group receives rapid preparation aimed at timely hip fracture repair, while the standard care group undergoes usual surgical timing and procedures. Both groups receive hip fracture repair and surgical care according to treating institution protocols. During the study, participants are monitored for mortality and other health outcomes up to 90 days after randomization. Assessments include walking ability, major cardiovascular events, delirium, pain levels, hospital discharge timing, and overall quality of life. Safety and recovery progress are closely followed to understand the impact of surgery timing on these important measures.

CONDITIONS

Brief Title

HIP Fracture Accelerated Surgical TreaTment And Care tracK 2 Trial

Research Team

V

Valerie Harvey

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here